Patents by Inventor Ryan W. Dellinger

Ryan W. Dellinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING MOTOR NEURON DISEASES
    Publication number: 20220160745
    Abstract: Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside, pterostilbene and a phosphodiesterase (PDE) inhibitor, including a PDE4 inhibitor such as ibudilast, and also including a thiol/cysteine donor, such as acetylcysteine.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 26, 2022
    Inventors: José María ESTRELA ARIGÜEL, María Elena OBRADOR PLA, Rosario SALVADOR, Ryan W. DELLINGER
  • Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
    Patent number: 9980924
    Abstract: A chemoprotective method for treating, inhibiting or preventing loss of barrier function in skin caused by ultraviolet (UV) light by using an effective amount of pterostilbene is provided. Pharmaceutical and nutraceutical compositions containing pterostilbene suitable for administration to an individual in order to prevent subsequent UV-mediated loss of barrier function in skin are provided.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: May 29, 2018
    Assignee: The Regents of the University of California
    Inventors: Frank L. Meyskens, Ryan W. Dellinger
  • TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED SKIN DAMAGE AND HYPERPLASIA
    Publication number: 20160067193
    Abstract: A chemoprotective method for treating, inhibiting or preventing DNA damage in skin and/or hyperplasia caused by ultraviolet (UV) light by using an effective amount of pterostilbene is provided. Pharmaceutical and nutraceutical compositions containing pterostilbene suitable for administration to an individual in order to prevent subsequent UV-mediated DNA damage and/or hyperplasia in skin are provided.
    Type: Application
    Filed: September 3, 2015
    Publication date: March 10, 2016
    Inventors: Frank L. Meyskens, JR., Ryan W. Dellinger
  • TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED LOSS OF BARRIER FUNCTION IN SKIN
    Publication number: 20160067194
    Abstract: A chemoprotective method for treating, inhibiting or preventing loss of barrier function in skin caused by ultraviolet (UV) light by using an effective amount of pterostilbene is provided. Pharmaceutical and nutraceutical compositions containing pterostilbene suitable for administration to an individual in order to prevent subsequent UV-mediated loss of barrier function in skin are provided.
    Type: Application
    Filed: September 3, 2015
    Publication date: March 10, 2016
    Inventors: Frank L. Meyskens, JR., Ryan W. Dellinger